Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Biomed Nanotechnol. 2014 Sep;10(9):1918–1936. doi: 10.1166/jbn.2014.1963

Figure 10.

Figure 10

Representative bioluminescence images from mice with Escherichia coli burn infections (day 0) and treated with successive fluences of photodynamic therapy or UVA light alone. (A) UVA control; (B) LC17 + UVA light; and (C) LC18+UVA light. There was no significant reduction in bioluminescence after application of either LC17 or LC18 without light exposure as a dark control. Reprinted with permission from [119], L. Huang, et al., Antimicrobial photodynamic therapy with decacationic monoadducts and bisadducts of [70]fullerene: In vitro and in vivo studies. Nanomedicine (Lond.) (2013).

© 2013, Future Science.